Tirilazad does not protect rat brain from brachytherapy-induced injury

Surgical Neurology

Volumn 45, Issue 5, 1996, Pages 482-489

  Bernstein, Mark ^a,b   Cabantog, Alberto M ^a   Glen, Jennifer ^a   Stiver, Shirley ^a   Mikulis, David ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Brachytherapy; brain injury; iodine 125; radiation damage; radiation protectors; tirilazad

Indexed keywords

21 AMINOSTEROID; IODINE 125; TIRILAZAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRACHYTHERAPY; BRAIN INJURY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GLIOMA; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION INJURY; RADIATION PROTECTION; RAT;

EID: 0029927016     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-3019(95)00131-X     Document Type: Article

References (31)

1. Baba T, Moriguchi M, Natori Y, Katsuki C, Inoue T, Fukui M. Magnetic resonance imaging of experimental rat brain tumors: histopathological evaluation. Surg Neurol 1990;34:378-82.
2. Barker M, Hoshino T, Gurcay O, Wilson CB, Nielson SL, Downie R, Eliason J. Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1973; 33:976-86.
3. Bernstein M, Ginsberg H, Glen J. Protection of iodine-125 brachytherapy brain injury in the rat with the 21-aminosteroid U-74389F. Neurosurgery 1992; 31: 923-28.
4. Bernstein M, Laperriere N, Glen J, Leung P, Thomason C, Landon AE. Brachytherapy for recurrent malignant astrocytoma. Int J Rad One Biol Phys 1994;30:1213-7.
5. Bernstein M, Laperriere N, Leung P, Lumley M, McKenzie S. Interstitial brachytherapy for malignant brain tumors: preliminary results. Neurosurgery 1990;26:371-80.
6. Bernstein M, Marotta T, Stewart P, Glen J, Resch L, Henkelman M. Brain damage from iodine-125 brachytherapy evaluated by MR imaging, a blood-brain barrier tracer, and light and electron microscopy in a rat model. J Neurosurg 1990;73:585-93.
7. Braughler JM, Hall ED, Jacobsen EJ, McCall JM, Means ED. The 21-aminosteroids: potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 1989;14:143-52.
8. Clark WM, Hotan T, Lauten JD, Coull BM. Therapeutic efficacy of tirilazad in experimental multiple cerebral emboil: a randomized, controlled trial. Crit Care Med 1994;22:1161-6.
9. d'Avella D, Cicciarello R, Albiero F, Mesiti M, Gagliardi ME, Russi E, d'Aquino A, Tomasello F, d'Aquino S. Quantitative study of blood-brain barrier permeability changes after experimental whole-brain radiation. Neurosurgery 1992;30:30-4.
10. Dooms GC, Hecht S, Brant-Zawadski M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986;158:149-55.
11. Fike JR, Cann CE, Phillips TL, Bernstein M, Gutin PH, Turowski P, Weaver KA, Davis RL, Higgins RJ, DaSilva V. Radiation brain damage induced by interstitial iodine-125 source: a canine model evaluated by quantitative computed tomography. Neurosurgery 1985; 16:530-7.
12. Griffin TW, Rasey JS, Bleyer WA. The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice. Cancer 1977;40:1109-11.
13. Groothius DR, Wright DC, Ostertag CB. The effect of iodine-125 interstitial radiotherapy on blood-brain barrier function in normal canine brain. J Neurosurg 1987;67:895-902.
14. Gutin PH, Bernstein M, Sano Y, Deen DF. Combination therapy with 1,3-bis(2-chloroethyl)-l-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy. Neurosurgery 1984;15:781-6.
15. Gutin PH, Prados MD, Phillips TL, Wara WM, Larson DA, Leibel SA, Sneed PK, Levin VA, Weaver KA, Silver P, Lamborn K, Lamb S, Ham B. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 1991;21:601-6.
16. Hall ED, Braughler JM, McCaul JM. New pharmacological treatment of acute spinal cord trauma. J Neurotrauma 1988;5:81-9.
17. Hall ED, Pazara KE, Braughler JM. 21-aminosteroid lipid peroxidation inhibitor U-74006F protects against cerebral ischemia in gerbils. Stroke 1988;19:977-1002.
18. Hall ED, Travis MA. Inhibition of arachidonic acid-induced vasogenic edema by nonglucocorticoid 21-aminosteroid U74006F. Brain Res 1988;451:350-2.
19. Hall ED, Yonkers PA. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 1988;19:340-4.
20. Hall ED, Yonkers PA, McCaul JM, Braughler JM. Effects of the 21-aminosteroid U74006F on experimental head injury. J Neurosurg 1988;68:456-61.
21. Kanamura K, Weir BKA, Simpson I, Witbeck T, Grace M. Effect of 21-aminosteroid U74006F on lipid peroxidation in subarachnoid clot. J Neurosurg 1991;74: 454-9.
22. King WA, Black KL, Ikezaki K, Conklin S, Becker DP. Tumor-associated neurological dysfunction prevented by lazaroids in rats. J Neurosurg 1991;74: 112-5.
23. Leibel SA, Gutin PH, Wara WM, Silver PS, Larson DA, Edwards MSB, Lamb SA, Ham B, Weaver KA, Barnett C, Phillips TL. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 1989;17:1129-39.
24. Matsui T, Asano T. Effects of new 21-aminosteroid Tirilazad Mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of Beagle dogs. Neurosurgery 1994;34:1035-9.
25. Natale JE, Schott RJ, Hall ED, Braughler JM, D'Alecy LG. Effects of the 21-aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 1988;19:1371-8.
26. Packer RJ, Zimmerman RA, Bilaniuk LT. Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer 1986;58:635-40.
27. Prados M, Leibel SA, Barnett CM, Gutin P. Interstitial brachytherapy for metastatic brain tumors. Cancer 1989;63:657-60.
28. Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP. Radiation effects on cerebral white matter: MR evaluation. AJNR 1987;8:431-7.
29. Turowski K, Fike JR, Cann CE, Higgins RJ, Davis RL, Gutin PH, Phillips TL, Weaver KA. Normal brain iodine-125 radiation damage: effect of dose and irradiated volume in a canine model. Radiology 1986;158: 833-8.
30. Young W, Wojak JC, DeCriscito V. 21-aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion of regional ischemia. Stroke 1988;19:1013-9.
31. Zuccarello M, Marsch JT, Schmitt G, Woodward J, Anderson DK. Effect of the 21-aminosteroid U74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1989;71:98-104.